METHODS FOR INCREASING SEPIAPTERIN PLASMA EXPOSURE
Application
US20260091037A1
Kind: A1
Apr 02, 2026
Inventors
Neil SMITH, Jonathan REIS
Abstract
The present invention features compositions including sepiapterin, or a pharmaceutically acceptable salt thereof, and methods for the treatment of BH4-related disorders. In some embodiments, these compositions and methods result in an increase in plasma. CSF, and/or brain exposure of sepiapterin.
CPC Classifications
A61K 31/519
A61K 9/0053
Filing Date
2025-05-13
Application No.
19206193